Showing results (461-470 of 604) with videos related to

Sort By:
Pageof 61
International Journal of Cancer|December 22, 1999
Treatment of patients with cisplatin-refractory testicular germ-cell cancer. German Testicular Cancer Study Group (GTCSG)C Bokemeyer, C Kollmannsberger, A Harstrick, et al.
Annals of the New York Academy of Sciences|June 14, 1993
The phenomenon of a high triglyceride response to an oral lipid load in healthy subjects and its link to the metabolic syndromeJ Schrezenmeir, I Keppler, S Fenselau, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 1, 1993
Long-term function of porcine islets and single cells embedded in barium-alginate matrixJ Schrezenmeir, B J Hering, L Gerö, et al.
International Journal of Molecular Medicine|December 19, 1998
Establishment of a quantitative RT-pCR for detection of vascular cell adhesion molecule-1 transcripts in endothelial cells after stimulation with advanced glycation endproductsT Kunt, T Forst, A Wilhelm, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 5, 2000
Serum levels of substance P are decreased in patients with type 1 diabetesT Kunt, T Forst, S Schmidt, et al.
Anti-Cancer Drugs|October 19, 2000
Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancerC Kollmannsberger, A Gerl, N Schleucher, et al.
The Annals of Thoracic Surgery|July 1, 1997
Management of left ventricular assist device infection with heart transplantationT W Prendergast, B A Todd, A J Beyer, et al.
Acta Endocrinologica. Supplementum|January 1, 1987
Effects of high and low doses of methimazole in patients with Graves' thyrotoxicosisG Benker, D Reinwein, H Creutzig, et al.
Deutsche Medizinische Wochenschrift (1946)|February 22, 2000
[Predictive genetic investigations. Individualization of diagnosis and treatment in families with multiple endocrine neoplasia type II]M Engelbach, T Kunt, P Kann, et al.
Annals of Hematology|August 1, 1993
Comparison of 5 vs 10 micrograms/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancerC Bokemeyer, H J Schmoll, B Metzner, et al.
Pageof 61